Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana S Leal

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|September 28, 2024
The BRD4 Inhibitor I-BET-762 Reduces HO-1 Expression in Macrophages and the Pancreas of MiceAna S Leal, Karen T Liby
Current Protocols in Pharmacology|October 17, 2018
Murine Models of Pancreatitis Leading to the Development of Pancreatic CancerAna S Leal, Karen T Liby
Bioorganic & Medicinal Chemistry|September 11, 2012
Synthesis of novel ursolic acid heterocyclic derivatives with improved abilities of antiproliferation and induction of p53, p21waf1 and NOXA in pancreatic cancer cellsAna S Leal, Rui Wang, Jorge A R Salvador, et al.
International Journal of Molecular Sciences|March 11, 2023
The Novel RXR Agonist MSU-42011 Differentially Regulates Gene Expression in Mammary Tumors of MMTV-Neu MiceLyndsey A Reich, Ana S Leal, Edmund Ellsworth, et al.
Chemmedchem|July 19, 2012
Semisynthetic ursolic acid fluorolactone derivatives inhibit growth with induction of p21(waf1) and induce apoptosis with upregulation of NOXA and downregulation of c-FLIP in cancer cellsAna S Leal, Rui Wang, Jorge A R Salvador, et al.
Organic & Biomolecular Chemistry|February 6, 2013
Synthesis of novel heterocyclic oleanolic acid derivatives with improved antiproliferative activity in solid tumor cellsAna S Leal, Rui Wang, Jorge A R Salvador, et al.
Pharmacology & Therapeutics|November 12, 2023
Retinoid X Receptor agonists as selective modulators of the immune system for the treatment of cancerAna S Leal, Pei-Yu Hung, Afrin Sultana Chowdhury, et al.
Carcinogenesis|September 24, 2016
The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancerAna S Leal, Michael B Sporn, Patricia A Pioli, et al.
Antioxidants (Basel, Switzerland)|December 30, 2025
Synthetic Oleanane Triterpenoids Reduce Tumor Growth and Promote an Anti-Tumor Immune Response Independent of Cancer <i>KEAP1</i> Mutational StatusChristopher J Occhiuto, Jessica A Moerland, Karen T Liby, et al.
Cancers|January 5, 2021
The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Models of Pancreatic CancerAna S Leal, Phillip Liu, Teresa Krieger-Burke, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|September 28, 2024
The BRD4 Inhibitor I-BET-762 Reduces HO-1 Expression in Macrophages and the Pancreas of MiceAna S Leal, Karen T Liby
Current Protocols in Pharmacology|October 17, 2018
Murine Models of Pancreatitis Leading to the Development of Pancreatic CancerAna S Leal, Karen T Liby
Bioorganic & Medicinal Chemistry|September 11, 2012
Synthesis of novel ursolic acid heterocyclic derivatives with improved abilities of antiproliferation and induction of p53, p21waf1 and NOXA in pancreatic cancer cellsAna S Leal, Rui Wang, Jorge A R Salvador, et al.
International Journal of Molecular Sciences|March 11, 2023
The Novel RXR Agonist MSU-42011 Differentially Regulates Gene Expression in Mammary Tumors of MMTV-Neu MiceLyndsey A Reich, Ana S Leal, Edmund Ellsworth, et al.
Chemmedchem|July 19, 2012
Semisynthetic ursolic acid fluorolactone derivatives inhibit growth with induction of p21(waf1) and induce apoptosis with upregulation of NOXA and downregulation of c-FLIP in cancer cellsAna S Leal, Rui Wang, Jorge A R Salvador, et al.
Organic & Biomolecular Chemistry|February 6, 2013
Synthesis of novel heterocyclic oleanolic acid derivatives with improved antiproliferative activity in solid tumor cellsAna S Leal, Rui Wang, Jorge A R Salvador, et al.
Pharmacology & Therapeutics|November 12, 2023
Retinoid X Receptor agonists as selective modulators of the immune system for the treatment of cancerAna S Leal, Pei-Yu Hung, Afrin Sultana Chowdhury, et al.
Carcinogenesis|September 24, 2016
The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancerAna S Leal, Michael B Sporn, Patricia A Pioli, et al.
Antioxidants (Basel, Switzerland)|December 30, 2025
Synthetic Oleanane Triterpenoids Reduce Tumor Growth and Promote an Anti-Tumor Immune Response Independent of Cancer <i>KEAP1</i> Mutational StatusChristopher J Occhiuto, Jessica A Moerland, Karen T Liby, et al.
Cancers|January 5, 2021
The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Models of Pancreatic CancerAna S Leal, Phillip Liu, Teresa Krieger-Burke, et al.
Pageof 3